Bokern M, Rentsch C, Quint J, Hunnicutt J, Douglas I, Schultze A
Pharmacoepidemiol Drug Saf. 2025; 34(1):e70086.
PMID: 39776023
PMC: 11706700.
DOI: 10.1002/pds.70086.
Krieger E, Kudryavtsev A, Sharashova E, Samodova O, Postoev V
Sci Rep. 2025; 15(1):1050.
PMID: 39774287
PMC: 11706959.
DOI: 10.1038/s41598-025-85360-0.
Patrascu R, Dumitru C, Laza R, Besliu R, Gug M, Zara F
J Clin Med. 2025; 13(24.
PMID: 39768431
PMC: 11677844.
DOI: 10.3390/jcm13247510.
Hafzalla G, Ji H, Jeganathan N
Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(4):e2024057.
PMID: 39655583
PMC: 11708943.
DOI: 10.36141/svdld.v41i4.16139.
Eiken A, Bliddal S, Villumsen M, Iversen K, Bundgaard H, Hasselbach R
PLoS One. 2024; 19(11):e0311260.
PMID: 39602471
PMC: 11602038.
DOI: 10.1371/journal.pone.0311260.
Patterns and trends in asthma incidence rates in main Asian and Western countries and their prediction to 2030.
Zheng Y, Lan L, Lu G, Gao Y
Chin Med J Pulm Crit Care Med. 2024; 2(3):188-196.
PMID: 39403411
PMC: 11471091.
DOI: 10.1016/j.pccm.2024.08.004.
Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action.
Liang Y, Quan X, Gu R, Meng Z, Gan H, Wu Z
Heliyon. 2024; 10(16):e35988.
PMID: 39247343
PMC: 11379597.
DOI: 10.1016/j.heliyon.2024.e35988.
Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis.
Moniz M, Pereira S, Soares P, Aguiar P, Donato H, Leite A
Front Public Health. 2024; 12:1367480.
PMID: 39139667
PMC: 11319152.
DOI: 10.3389/fpubh.2024.1367480.
Impact of COVID-19 on asthma control in Kirkuk City: an analysis of post-pandemic trends.
Kamal B, Khalaf M
J Med Life. 2024; 17(3):292-295.
PMID: 39044936
PMC: 11262596.
DOI: 10.25122/jml-2023-0175.
Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis: Exploring Therapeutic Options.
Soni S, Antonescu L, Ro K, Horowitz J, Mebratu Y, Nho R
Am J Pathol. 2024; 194(10):1807-1822.
PMID: 39032604
PMC: 11423761.
DOI: 10.1016/j.ajpath.2024.06.004.
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.
Elneima O, Hurst J, Echevarria C, Quint J, Walker S, Siddiqui S
ERJ Open Res. 2024; 10(4).
PMID: 39010888
PMC: 11247371.
DOI: 10.1183/23120541.00982-2023.
Impact of the COVID-19 Pandemic on Hospital Admission Rate, Length of Stay, and Mortality Rate for Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Retrospective Study.
Abdulfattah O, Kohli A, White P, Michael C, Alnafoosi Z
J Community Hosp Intern Med Perspect. 2024; 14(2):1-8.
PMID: 38966505
PMC: 11221434.
DOI: 10.55729/2000-9666.1311.
Impact of the COVID-19 infection on children with allergic diseases in China.
Qian J, Zhang G, Wu H, Sha L
Pediatr Res. 2024; 97(1):360-364.
PMID: 38937639
DOI: 10.1038/s41390-024-03365-3.
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study.
Pina Belmonte A, Madrazo M, Piles L, Rubio-Rivas M, de Jorge Huerta L, Gomez Antunez M
Can J Respir Ther. 2024; 60:86-94.
PMID: 38855380
PMC: 11161176.
DOI: 10.29390/001c.118514.
COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms.
Bai X, Niu Y, Wei S, Zhu Z, Xu M, Liu H
Clin Respir J. 2024; 18(6):e13790.
PMID: 38817043
PMC: 11139969.
DOI: 10.1111/crj.13790.
[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases].
Villar-Alvarez F, Martinez-Garcia M, Jimenez D, Farinas-Guerrero F, Ortiz de Lejarazu-Leonardo R, Lopez-Campos J
Open Respir Arch. 2024; 3(2):100097.
PMID: 38620748
PMC: 7983358.
DOI: 10.1016/j.opresp.2021.100097.
The influence of novel coronavirus pneumonia on chronic disease management of asthma-a narrative review.
Chen X, Deng J
J Thorac Dis. 2024; 16(2):1590-1600.
PMID: 38505017
PMC: 10944750.
DOI: 10.21037/jtd-23-1139.
Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection.
Wang J, Ren J, Li X, Wang J, Chang C, Sun L
Front Med (Lausanne). 2024; 10:1276763.
PMID: 38264053
PMC: 10804846.
DOI: 10.3389/fmed.2023.1276763.
Socioeconomic and Health Determinants of the Prevalence of COVID-19 in a Population of Children with Respiratory Diseases and Symptoms.
Wypych-Slusarska A, Krupa-Kotara K, Oleksiuk K, Glogowska-Ligus J, Slowinski J, Niewiadomska E
Children (Basel). 2024; 11(1).
PMID: 38255401
PMC: 10814875.
DOI: 10.3390/children11010088.
Risk factors for SARS-CoV-2 infection: a test-negative case-control study with additional population controls in Norway.
Sarjomaa M, Zhang C, Tveten Y, Kersten H, Reiso H, Eikeland R
BMJ Open. 2024; 14(1):e073766.
PMID: 38191258
PMC: 10806780.
DOI: 10.1136/bmjopen-2023-073766.